A perspective on surrogate endpoints in controlled clinical trials (Q5424596): Difference between revisions
From MaRDI portal
Created a new Item |
Created claim: Wikidata QID (P12): Q35805910, #quickstatements; #temporary_batch_1711234560214 |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2340418739 / rank | |||
Normal rank | |||
| Property / Wikidata QID | |||
| Property / Wikidata QID: Q35805910 / rank | |||
Normal rank | |||
| links / mardi / name | links / mardi / name | ||
Latest revision as of 01:14, 24 March 2024
scientific article; zbMATH DE number 5208640
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A perspective on surrogate endpoints in controlled clinical trials |
scientific article; zbMATH DE number 5208640 |
Statements
A perspective on surrogate endpoints in controlled clinical trials (English)
0 references
5 November 2007
0 references
